Provided by Tiger Trade Technology Pte. Ltd.

INSILICO

51.900
+1.4002.77%
Volume:11.19M
Turnover:576.31M
Market Cap:30.26B
PE:-11.58
High:52.850
Open:49.400
Low:49.260
Close:50.500
52wk High:80.900
52wk Low:29.980
Shares:583.00M
HK Float Shares:583.00M
Volume Ratio:0.60
T/O Rate:1.92%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-4.480
ROE:--
ROA:-1.36%
PB:7.05
PE(LYR):-11.58
PS:28.56

Loading ...

Insilico Commences Phase 3 Trial for Rentosertib

Stock News
·
Jul 08

Insilico Medicine Initiates Phase III Trial of IPF Drug Rentosertib

Reuters
·
Jul 07

Insilico Initiates Phase Iii Clinical Trial for Rentosertib, Its Ai-empowered Tnik Inhibitor for Idiopathic Pulmonary Fibrosis

THOMSON REUTERS
·
Jul 07

Movement Alert|Insilico Medicine Falls 5.11% in Regular Trading, Takeda Deal Gains Fully Priced In Amid Continued Lock-Up Selling Pressure

Market Focus
·
Jul 07

INSILICO expands share capital by 0.53% through option exercises and award vesting

Bulletin Express
·
Jul 06

Insilico Medicine Files HKEX Next-day Disclosure Return, Share Capital Rises by 3,052,484 Shares

Reuters
·
Jul 06

Movement Alert|Insilico Medicine Falls 6.32% in Regular Trading, Post-Takeda Deal Selling Pressure Persists

Market Focus
·
Jul 03

PRESS Digest -wall Street Journal - July 2

Reuters
·
Jul 02

Insilico Medicine Announces Collaboration with Takeda to Advance Strategic AI Drug Discovery

THOMSON REUTERS
·
Jul 02

Insilico Medicine Cayman Topco: Total Deal Value to Approximately $600 Mln

THOMSON REUTERS
·
Jul 02

Movement Alert|Insilico Medicine Rises 5.81% in Regular Trading, Strategic Collaboration with Takeda Worth Up to $600 Million

Market Focus
·
Jul 02

Insilico Medicine Announces Strategic Collaboration with Takeda for AI-Driven Drug Discovery

Stock News
·
Jul 02

Insilico Medicine and Takeda Sign AI-Driven Drug Discovery Deal Worth up to USD600 million

Bulletin Express
·
Jul 02

Insilico Medicine Cayman Announces Drug Discovery Collaboration with Takeda Worth up to $600 Million

Reuters
·
Jul 02

Insilico Medicine Cayman Topco - Takeda Granted Exclusive Worldwide Rights to Develop and Commercialize Collaboration Therapeutics

THOMSON REUTERS
·
Jul 02

Insilico Medicine Cayman Topco - Deal Value up to Usd600 Mln Including USD60 Mln in Upfront and Near-term Payments

THOMSON REUTERS
·
Jul 02

Insilico Medicine Cayman Topco - Voluntary Announcement Insilico Medicine and Takeda Achieved Strategic Ai-powered Drug Discovery Collaboration Worth up to Usd600 Mln

THOMSON REUTERS
·
Jul 02

Takeda Will be Granted Exclusive Worldwide Rights Under Insilico Deal to Develop, Manufacture and Commercialize New Drugs - WSJ

THOMSON REUTERS
·
Jul 02

Takeda, Insilico Strike AI Drug-discovery Deal Worth up to $600.0 Million

Dow Jones
·
Jul 02

Insilico Leadership Voluntarily Extends Share Lock-Up Period

Stock News
·
Jun 30